Long-Term Follow-Up of Radical Retropubic Prostatectomy for Prostate Cancer
| Autor: | Mark W. Riggs, M. G. Haddock, Gregory P. Swanson, John D. Earle |
|---|---|
| Rok vydání: | 2002 |
| Předmět: |
Adult
Male medicine.medical_specialty Time Factors Urology medicine.medical_treatment Population Cohort Studies Prostate cancer Prostate medicine Humans education Aged Neoplasm Staging Retrospective Studies Prostatectomy education.field_of_study business.industry Prostatic Neoplasms Cancer Middle Aged medicine.disease Combined Modality Therapy Survival Analysis Surgery Treatment Outcome medicine.anatomical_structure Cohort Neoplasm Recurrence Local business Follow-Up Studies Radical retropubic prostatectomy Cohort study |
| Zdroj: | European Urology. 42:212-216 |
| ISSN: | 0302-2838 |
| DOI: | 10.1016/s0302-2838(02)00276-2 |
| Popis: | Objectives: The ultimate outcome of patients after radical prostatectomy is often predicted from statistical projections of short-term follow-up. Only actual long-term follow-up can demonstrate true outcome. Methods: One hundred thirty-one patients underwent retropubic prostatectomy for clinically organ confined prostate cancer and have been followed for a minimum of 22.5 years. Preoperatively, all but 12 had clinically palpable cancer. Results: Overall survival in these patients was similar to an age-matched population, with 65% alive at 15 years, and 23% alive at 25 years. Thirty-seven percent of the patients recurred and 24% of all the patients died of prostate cancer. For patients with pathologically organ confined disease, 27% recurred, while those with extension outside the gland or positive nodes had an 83% recurrence rate. Although, the median time to recurrence was 7 years, recurrences occurred at a steady-state throughout the length of follow-up. Patients with higher grade tumors, even if organ confined, were significantly more likely to recur. Conclusions: In a cohort of patients treated with radical prostatectomy for predominantly palpable disease, long-term follow-up (79% deceased) reveals that 37% will recur and 24% will die of prostate cancer. Almost half the recurrences occurred after 10 years, indicating that reports with shorter follow-up will underestimate the recurrence rate. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect